Drugs Made In America Acquisition (DMII) Total Current Liabilities (2024 - 2025)

Drugs Made In America Acquisition (DMII) reported Total Current Liabilities of $300864.0 for Q4 2025, up 18.09% year-over-year from $254783.0 in Q4 2024, and down 55.58% quarter-over-quarter from $677345.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) Total Current Liabilities (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has 2 years of Total Current Liabilities data on file, last reported at $300864.0 in Q4 2025.

  • Total Current Liabilities for Q4 2025 came in at $300864.0, up 18.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $300864.0 (up 18.09% YoY), and the FY2025 annual result was $300864.0, up 18.09% from the prior year.
  • Total Current Liabilities slipped to $300864.0 in Q4 2025 per DMII's latest filing, from $677345.0 in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $677345.0 in Q3 2025 and troughed at $254783.0 in Q4 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - 264,756.00
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - 634,612.00
3 Berto Acquisition 311.56 Mn 311.56 Mn - 885,401.00
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 945,150.00
5 Centurion Acquisition 310.21 Mn 310.21 Mn - 155,870.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - 131,332.00
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - 17.33 Mn
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - 239,898.00
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - 1.85 Mn
10 Drugs Made In America Acquisition 129.34 Mn 129.34 Mn - 300,864.00

Historic Data

Download Data
DateValue
Dec 31, 2025 300,864.00
Sep 30, 2025 677,345.00
Dec 31, 2024 254,783.00